| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| AMERICAN RENAL ASSOCIATES Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BECTON DICKINSON | 164,00 | +0,24 % | BD (Becton, Dickinson and Company): BD Extends Leadership in Advanced Tissue Regeneration Through Continued Clinical Innovation | STANCE trial surpasses a key enrollment milestone, advancing the clinical evaluation of GalaFLEX LITE Scaffold and generating evidence to support its use in breast revision surgery for... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 40,300 | -0,31 % | Cyberattack on Boston Scientific causes global ops disruption | ||
| ALIGN TECHNOLOGY | 136,50 | +0,37 % | Align Technology Wins China Patent Case Against Angelalign | WASHINGTON (dpa-AFX) - Align Technology, Inc. (ALGN), said the Jinan Intermediate People's Court in China ruled in its favor in a patent infringement case against Angelalign Technology's Chinese... ► Artikel lesen | |
| BAXTER | 22,450 | -0,44 % | Dividendenbekanntmachungen (28.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 361 DEGREES INTERNATIONAL LTD KYG884931042 0,222 HKD 0,0243 EUR ABC-MART INC JP3152740001 40 JPY 0,2152 EUR ADMIE IPTO HOLDING... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,240 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| ELEVANCE HEALTH | 344,30 | +1,12 % | Elevance Health Raises FY26 Guidance; Expects To Return To At Least 12% Adj. EPS Growth In 2027 | WASHINGTON (dpa-AFX) - Elevance Health (ELV) said second quarter results exceeded its outlook. The company increased 2026 EPS guidance to at least $20.10, and lifted 2026 adjusted EPS guidance... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 30,000 | 0,00 % | AMN Healthcare Services, Inc.: Amn Healthcare Announces Second Quarter 2026 Results | Quarterly revenue of $673 million and adjusted EBITDA of $73 million;
GAAP income of $0.53/share and adjusted EPS of $0.77
DALLAS, Aug. 6, 2026 /PRNewswire/ --... ► Artikel lesen | |
| AXOGEN | 43,960 | -1,04 % | Truist stuft AxoGen mit "Buy" ein und verweist auf starkes Wachstumspotenzial | ||
| ADDUS HOMECARE | 99,50 | -2,45 % | Are Options Traders Betting on a Big Move in Addus HomeCare Stock? | ||
| SINTX TECHNOLOGIES | 1,490 | -0,67 % | SINTX Technologies, Inc.: SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement | SALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a company focused on advanced silicon nitride materials and medical technologies... ► Artikel lesen | |
| ALPHATEC | 7,900 | +1,28 % | Alphatec signals $140M adjusted EBITDA guidance for 2026 while maintaining ~$882M revenue outlook | ||
| AVANOS MEDICAL | 21,600 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 27.07.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 27.07.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 27.07.2026.ISIN NameCA05335P1099 AUXLY... ► Artikel lesen | |
| OPTION CARE HEALTH | 20,800 | 0,00 % | Option Care Health, Inc.: Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026 | BANNOCKBURN, Ill., July 29, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate... ► Artikel lesen | |
| ATRICURE | 42,800 | +1,90 % | Piper Sandler raises AtriCure stock price target on quality measure | ||
| ANGIODYNAMICS | 13,600 | +0,74 % | Biotech Stocks At 52-Week Highs - Cumberland Pharmaceuticals, Maravai LifeSciences, AngioDynamics, Acadia Healthcare, Teladoc Health | BENTONVILLE (dpa-AFX) - The following biotech stocks reached a 52-week high on July 15, 2026, driven by catalysts such as recent business developments or positive quarterly reports.Cumberland... ► Artikel lesen |